Literature DB >> 15951446

Direct determination of unbound intrinsic drug clearance in the microsomal stability assay.

Claudio Giuliano1, Mark Jairaj, Christian M Zafiu, Ralph Laufer.   

Abstract

The microsomal stability assay is commonly used to rank compounds according to their metabolic stability. Determination of the unbound intrinsic clearance (CL(in,u)) is essential for the accurate comparison of compounds, since nonspecific binding to microsomes can lead to an underestimation of the microsomal clearance. In this study, a new method (linear extrapolation in the stability assay, LESA) was established, which allows direct calculation of CL(in,u) from microsomal stability data, without the need to independently determine the fraction of free (unbound) drug. The method was validated using nine drugs with different chemical structures and physicochemical properties. The CL(in,u) of these compounds was extrapolated from the intrinsic clearance values obtained at different concentrations of human liver microsomes and compared with that calculated by the conventional method, using microsomal intrinsic clearance values and the free fraction of drug determined by equilibrium dialysis, ultracentrifugation, or ultrafiltration. A good agreement was observed between the data generated by the LESA method and those determined by conventional procedures. The method was further evaluated using a published dataset for 10 additional drugs and found to yield intrinsic clearance data comparable to the previously reported values. LESA provides a convenient and rapid method to determine the influence of microsome binding on intrinsic clearance in a single assay.

Entities:  

Mesh:

Year:  2005        PMID: 15951446     DOI: 10.1124/dmd.105.005033

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  6 in total

1.  Enzyme Kinetics of Oxidative Metabolism-Cytochromes P450.

Authors:  Ken Korzekwa
Journal:  Methods Mol Biol       Date:  2021

2.  Toxicity and intraocular properties of a novel long-acting anti-proliferative and anti-angiogenic compound IMS2186.

Authors:  Iryna A Falkenstein; Lingyun Cheng; Flossie Wong-Staal; Ajay M Tammewar; Erin C Barron; Gabriel A Silva; Qi-Xiang Li; Dehua Yu; Michelle Hysell; Guohong Liu; Ning Ke; James E Macdonald; William R Freeman
Journal:  Curr Eye Res       Date:  2008-07       Impact factor: 2.424

3.  Metabolism and pharmacokinetics characterization of metarrestin in multiple species.

Authors:  Elias C Padilha; Pranav Shah; Amy Q Wang; Marc D Singleton; Emma A Hughes; Dandan Li; Kelly A Rice; Kylie M Konrath; Samarjit Patnaik; Juan Marugan; Udo Rudloff; Xin Xu
Journal:  Cancer Chemother Pharmacol       Date:  2020-03-17       Impact factor: 3.333

4.  Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents.

Authors:  Suresh B Lakshminarayana; Tan Bee Huat; Paul C Ho; Ujjini H Manjunatha; Véronique Dartois; Thomas Dick; Srinivasa P S Rao
Journal:  J Antimicrob Chemother       Date:  2014-11-11       Impact factor: 5.758

5.  Integration of in vitro binding mechanism into the semiphysiologically based pharmacokinetic interaction model between ketoconazole and midazolam.

Authors:  Sara K Quinney; Shawn Knopp; Chien Chang; Stephen D Hall; Lang Li
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-09-11

6.  Use of Physiologically-Based Kinetics Modelling to Reliably Predict Internal Concentrations of the UV Filter, Homosalate, After Repeated Oral and Topical Application.

Authors:  Abdulkarim Najjar; Andreas Schepky; Christopher-Tilman Krueger; Matthew Dent; Sophie Cable; Hequn Li; Sebastien Grégoire; Laurene Roussel; Audrey Noel-Voisin; Nicola J Hewitt; Estefania Cardamone
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.